top of page
RT Banners.png

We invite you to engage in an interactive nintely minute roundtable led by EverythingALS consortia of Pharma partners, sensor companies, neurologists, data scientists, regulators and patients to help advance the discovery and implementation of ALS digital biomarkers in clinical trials through our collaborative efforts.

 

Joining our participatory roundtable, you will be the first to learn about our latest study results on ALS digital biomarkers as well as have the opportunity to hear why major pharmaceutical companies have joined the consortium to partner in EverythingALS research, which will be expanded to include analyzing data from wearables and smartphones.

  

As always, we approach each roundtable to encourage out-of-the-box thinking, and to kick it off, we have an exciting agenda! Take a look below. 

This is an invite only event.

Speakers

Hosts & Speakers 

  • Twitter
  • LinkedIn
  • Twitter
  • png-transparent-hyperlink-computer-icons-link-text-logo-number-removebg-preview
  • icons8-link-60
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • LinkedIn
  • icons8-link-60
  • icons8-link-60
  • LinkedIn

Agenda

Monday June 3rd, 2024

     11:30 AM - 1 PM ET   I   8:30 AM - 10:00 AM PT

Welcome, Updates, and Announcements

Welcomes and introductions, agenda and new members of the Consortia, Board, and partners network

Indu Navar

Keynote:

Hope and Action: A Journey through Life as Young Adult with ALS

Brooke Eby     

Speech & Listener Effort Paper: the Path to Speech Progression as a Clinically Meaningful Digital End Point

Dr. Lyle W. Ostrow and Dr.Ernest Fraenkel

     

Question & Answer

EverythingALS Consortia Paper: Advancing a Roadmap to DHTs in Care and Clinical Research

EverythingALS Industry Consortia Representatives

EverythingALS Industry Consortia Representatives

Breakouts by Work Stream

 

Final read-outs & next steps

 

Closing Remarks 

Digital Biomarker Summit in Aug 2024

Agenda

Participants

bottom of page